Developer of ELD607, an inhaled lung-specific immunomodulator aimed at neutrophilic lung inflammation.

At a glance

  • HQ: Chapel Hill
  • Affiliation: UNC

See the full company record.

Founders, funding history and recent signals. Free accounts open immediately.

Listed roles

All Triangle roles

Checking listed roles…